International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Prep: Cook: Serves:

Zambon Open Accelerator 2019 awards ceremony

Open Accelerator, an international programme supporting digital healthcare technologies that improve patient experience, has launched its 2020 ‘Call for Solutions’.

Created by Zcube, the research venture of Italian pharmaceutical company Zambon, the accelerator focuses on four key areas: ‘digital prevention, monitoring and therapeutics’, ‘digital diagnostics’, ‘virtual health’ and ‘clinical trials digitalisation’. Successful applicants will take part in a four-week programme, and could win up to EUR €100,000 seed investment for their project. In response to the Covid-19 pandemic, a ‘Special Challenge’ will be dedicated to new forms of communication in healthcare.

Elena Zambon, creator of the programme said: “Digital solutions have never been such a vital support for patients and caregivers as they have at this time.

“This programme is yet another way in which we are pursuing with conviction our commitment to improving patients’ lives, integrating cure and care with a multidisciplinary approach.”

Submissions are open until 20 July 2020. To find out more about how to apply visit the Open Accelerator website.

For more information on the latest Parkinson’s research please visit the EPDA website.

Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests

Last Month

Next Month

Go Back

Share this story

Comments

Interviews

A window into the world of Parkinson’s

We spoke to the creator of ‘The Adventures of an Aspiring Rockstar’

New Parkinson’s survey to campaign for better quality of life

Have your say on living with Parkinson’s

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Tickets for the online event are now on sale

Study suggests why neurons die in Parkinson’s disease

Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Interviews

A window into the world of Parkinson’s

Advances

New Parkinson’s survey to campaign for better quality of life

Global update

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

International programme seeks innovative health tech solutions

News

Author: Saskia MairPublished: 11 June 2020

Last Month

Next Month

Share this story

Comments

Related articles

Interviews

A window into the world of Parkinson’s

Advances

New Parkinson’s survey to campaign for better quality of life

Global update

Tickets on sale for ‘Insight into Parkinson’s’ summit 2019

Study suggests why neurons die in Parkinson’s disease

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

{title}

Subscribe

Sign in